top of page
hero-2.png

News & Publications

News

Engimmune Therapeutics strikes ‘fast-forward’ micro-fluidics collaboration with Swiss innovator CSEM

December 13, 2023

Engimmune Therapeutics Announces the Appointment of Dr Annalisa D’Andrea to its Board of Directors

May 23, 2023

Engimmune Therapeutics appoints Dr. Lars Nieba as Chief Executive Officer

April 19, 2023

Publications

High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity

October 11, 2022

bottom of page